New Haven Pharmaceuticals said data on the antiplatelet effects of Durlaza will be presented in a poster session during the American Heart Association Scientific Sessions that begin this weekend in Orlando, Florida. Read More »

The cancer-fighting drug Imbruvica (ibrutinib) recently received the 2015 Prix Galien Award for Best Pharmaceutical Agent. Read More »

Dallas-based oncology drug development company Arog Pharmaceuticals, Inc. named Ada Braun senior vice president of clinical development on Monday. Read More »

A report released Tuesday by the Generic Pharmaceutical Association (GPhA) indicates generic drugs generated significant savings for all stakeholders in the health care industry in 2014 and over the past decade. Read More »

CVS/pharmacy said Monday its customers can show their support for groundbreaking cancer research by participating in its second annual in-store fundraising campaign to benefit Stand Up To Cancer (SU2C). Read More »

U.S.-based drugmaker Pfizer said this week it is tackling the rising costs of prescription medicines head on by expanding its patient assistance program so that more people can gain access to free medicines. Read More »

Maine residents will now have easy access to high-quality medical care with the opening of the first MinuteClinics in the state this week. Read More »

Johnson & Johnson said this week it has entered a deal to acquire hepatitis B virus (HBV) drug developer Novira Therapeutics Inc. by the end of the year. Read More »

PharMerica Corp. announced Thursday that it has completed its acquisition of Luker Pharmacy Management, although terms were not publicly disclosed. Read More »

The American Society of Hematology's annual meeting taking place Dec. 5 to Dec. 8 in Orlando, Florida. Read More »

Clinical studies showed that Nucala was effective in reducing exacerbations that would require hospitalization. Read More »

AstraZeneca has entered into a deal to acquire ZS Pharma for $2.7 billion, giving AstraZeneca access to ZS Pharma's treatments for hyperkalemia. Read More »

Allergan has entered into a $50 million licensing deal to develop and commercialize tavilermide (MIM-D3), Mimetogen Pharmaceutical's lead product for the treatment of dry eye syndrome (DES). Read More »

Findings from a recent survey by Cigna analyzing workplace wellness in India were released last week during a forum sponsored by Cigna TTK Health Insurance Company Limited, joint venture between Cigna and Indian conglomerate TTK Group. Read More »

Walgreens recently said it will begin implementing Epic System's electric health record (EHR) platform across its more than 400 in-store health care clinics around the nation early next year. Read More »

Clinical-stage biopharmaceutical company Novavax said Monday it has started a Phase 3 clinical trial of its vaccine for the protection against respiratory syncytial virus (RSV) in older adults. Read More »

Hospice Pharmacy Solutions of Dallas, a pharmacy benefit management (PBM) service, announced Monday that it has merged with Sacramento-based hospice PBM Outcome Resources. Read More »

Out of concern for the individuals that use its branded medicines, Horizon Pharma announced Wednesday that it is re-evaluating its relationship with pharmacy benefit manager Express Scripts. Read More »

The Pharmacy Practice Model Initiative has been renamed Practice Advancement Initiative (PAI), according to an announcement from the American Society of Health-System Pharmacists (ASHP) Foundation and the ASHP. Read More »

An analysis of clinical trials of Praluent showed that trial participants had a lower LDL cholesterol after the eight-week trial, according an announcement from Sanofi and Regeneron Pharmaceuticals Inc.  Read More »